Erratum to: Characterizing Benefit from Temozolomide in MGMT Promoter Unmethylated and Methylated Glioblastoma: A Systematic Review and Meta-analysis

Guardat en:
Dades bibliogràfiques
Publicat a:Neurooncol Adv
Autors principals: Alnahhas, Iyad, Alsawas, Mouaz, Rayi, Appaji, Palmer, Joshua D, Raval, Raju, Ong, Shirley, Giglio, Pierre, Murad, Mohammad Hassan, Puduvalli, Vinay
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2021
Matèries:
Erratum
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8272530/
https://ncbi.nlm.nih.gov/pubmed/34258581
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/noajnl/vdab095
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars